Literature DB >> 21776593

Therapeutic efficacy of Dormectin, Ivermectin and Levamisole against different stages of Trichinella spiralis in rats.

Gamal A Soliman1, Eman S Taher, Maha A Mahmoud.   

Abstract

OBJECTIVE: Three commonly used antihelmenthic drugs including Dormectin (0.2 mg/kg), Ivermectin (0.2 mg/kg) and Levamisole (7.5 mg/kg) were examined for their antihelmenthic efficacy against experimental Trichinella spiralis infection in rats.
METHODS: One hundred and twenty rats were orally infected with 500 T. spiralis larvae. Drugs were tested against adult worms at 4th day, against migrating larvae at 10th days and against encysted larvae at 35th day post infection (dpi). Rats were sacrificed five days post treatment. Mature worms and migrating larvae counts were detected.
RESULTS: Significant effect was detected in rats treated with Dormectin and Ivermectin compared to non-treated controls. Dormectin showed an efficacy of 97.75% and 86.23% in eliminating both mature worms and migrating larvae respectively. Ivermectin showed an efficacy of 94.99% and 83.85% respectively. However, Levamisole was the least effective drug; its efficacy was 4.83% and 3.57% against mature worms and migrating larvae respectively.
CONCLUSION: All of the tested drugs failed to inhibit the encysted larvae in the diaphragms. Moreover, T. spiralis infection in rats reduced significantly the values of total proteins, and albumin while globulin, urea and creatinine values were significantly increased together with AST and ALT activities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21776593     DOI: 10.5152/tpd.2011.22

Source DB:  PubMed          Journal:  Turkiye Parazitol Derg        ISSN: 1300-6320


  6 in total

1.  Acute renal failure associated with albendazole therapy in a patient with trichinosis.

Authors:  Cassandra Marie Batzlaff; Jakrapun Pupaibool; M Rizwan Sohail
Journal:  BMJ Case Rep       Date:  2014-05-19

2.  Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice.

Authors:  Dalia A Elmehy; Marwa A Hasby Saad; Gamal M El Maghraby; Mona F Arafa; Nema A Soliman; Heba H Elkaliny; Dina I Elgendy
Journal:  Parasitol Res       Date:  2021-05-04       Impact factor: 2.289

3.  Investigation of The Effect of Curcumin on Oxidative Stress, Local Inflammatory Response, COX-2 Expression, and Microvessel Density in Trichinella Spiralis Induced Enteritis, Myositis and Myocarditis in Mice.

Authors:  A M R Hamed; I R Abdel-Shafi; M D A Elsayed; A M Mahfoz; S E Tawfeek; M S A Abdeltawab
Journal:  Helminthologia       Date:  2022-05-04       Impact factor: 1.176

Review 4.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

5.  Potential therapeutic effect of platelet-rich plasma and albendazole on the muscular phase of experimental Trichinella spiralis infection.

Authors:  Fatma M A Eissa; Ahmed H A Eassa; Rabab S Zalat; Mohamed S Negm; Marwa A Elmallawany
Journal:  Food Waterborne Parasitol       Date:  2022-09-14

6.  Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice.

Authors:  Maha M A Basyoni; Abdel-Aleem A El-Sabaa
Journal:  Korean J Parasitol       Date:  2013-06-30       Impact factor: 1.341

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.